Cargando…

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis

Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by chronic neuroinflammation, demyelination, and axonal damage. Infiltration of activated lymphocytes and myeloid cells are thought to be primarily responsible for white matter damage and axonopathy. Over time, this neur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yandamuri, Soumya S., Lane, Thomas E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871863/ https://www.ncbi.nlm.nih.gov/pubmed/27242796 http://dx.doi.org/10.3389/fimmu.2016.00189

Ejemplares similares

Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
por: Kerschensteiner, Martin, et al.
Publicado: (2004)

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
por: Mammana, Santa, et al.
Publicado: (2018)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis
por: Salapa, Hannah E., et al.
Publicado: (2017)

Diffusion tensor imaging as a tool to detect presymptomatic axonal degeneration in a preclinical spinal cord model of amyotrophic lateral sclerosis
por: Gatto, Rodolfo Gabriel
Publicado: (2018)

The emerging roles of piezo1 channels in animal models of multiple sclerosis
por: Yang, Kai, et al.
Publicado: (2022)

Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis
por: Xun, Chengfeng, et al.
Publicado: (2022)

Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2016)

Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair
por: Lemus, Hernan Nicolas, et al.
Publicado: (2018)

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
por: Mestre, Leyre, et al.
Publicado: (2019)

Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis
por: Witte, Maarten E., et al.
Publicado: (2019)

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
por: Manresa-Arraut, Alba, et al.
Publicado: (2018)

Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis
por: Shahi, Shailesh K., et al.
Publicado: (2022)

Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis
por: Rossi, Barbara, et al.
Publicado: (2016)

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
por: Singh, Shailender, et al.
Publicado: (2013)

Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?
por: Lee, Jae Young, et al.
Publicado: (2014)

Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis
por: Singh, Shailender, et al.
Publicado: (2017)

Expression of Concern: Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
Publicado: (2020)

Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
por: van den Hoogen, Ward J., et al.
Publicado: (2017)

Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis
por: Shahi, Shailesh K., et al.
Publicado: (2019)

What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?
por: Hassani, Asma, et al.
Publicado: (2022)

Sustained Infiltration of Neutrophils Into the CNS Results in Increased Demyelination in a Viral-Induced Model of Multiple Sclerosis
por: Skinner, Dominic D., et al.
Publicado: (2022)

Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis
por: Skundric, Dusanka S.
Publicado: (2015)

Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes
por: Frazzei, Giulia, et al.
Publicado: (2022)

Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosis
por: Leung, Gary, et al.
Publicado: (2017)

Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
por: Decker, William K., et al.
Publicado: (2017)

High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis
por: Singh, Avadhesh Kumar, et al.
Publicado: (2017)

A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis
por: Swan, Gregory, et al.
Publicado: (2021)

Editorial: Imaging the immune response in inflammatory preclinical in vivo models
por: Erreni, M., et al.
Publicado: (2023)

Fc multimers effectively treat murine models of multiple sclerosis
por: Wang, Jin, et al.
Publicado: (2023)

Corrigendum: A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis
por: Swan, Gregory, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis
por: Pelisch, Nicolas, et al.
Publicado: (2015)

Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis
por: Totoiu, Minodora O., et al.
Publicado: (2004)

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
por: Flórez-Grau, Georgina, et al.
Publicado: (2018)

Axonal Damage in Pediatric Multiple Sclerosis
por: Kuntz, Nancy L.
Publicado: (2015)

Animal models of Multiple Sclerosis
por: Procaccini, Claudio, et al.
Publicado: (2015)

Animal Models of Multiple Sclerosis
por: Young, Colin R., et al.
Publicado: (2008)

Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
por: Stamoula, Eleni, et al.
Publicado: (2021)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hamo5gh2rb7mj4gbcikeafeptj